Hologic, Inc. (Nasdaq: HOLX) announced Friday that the Food and Drug Administration has approved the company's Pharmaceutical Makena, formerly known ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE